Terms: = Prostate cancer AND B2M, P61769, 567, ENSG00000166710 AND Diagnosis
25 results:
1. Partial gland ablation with high intensity focal ultrasound impact on genito-urinary function and quality of life: our initial experience.
Fugaru I; Bouhadana D; Marcq G; Moryousef J; Rompré-Brodeur A; Meng A; Loutochin O; Loutochin G; Anidjar M; Bladou F; Sanchez-Salas R
Can J Urol; 2024 Feb; 31(1):11784-11792. PubMed ID: 38401258
[TBL] [Abstract] [Full Text] [Related]
2. Increasing aggressive prostate cancer.
Shah N; Ioffe V; Chang JC
Can J Urol; 2022 Dec; 29(6):11384-11390. PubMed ID: 36495581
[TBL] [Abstract] [Full Text] [Related]
3. Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation.
Totaro A; Di Gianfrancesco L; Pinto F; Racioppi M; Palermo G; Campetella M; Santoro AA; Arbia G; Sacco E
Urologia; 2021 Aug; 88(3):194-199. PubMed ID: 33579180
[TBL] [Abstract] [Full Text] [Related]
4. Serum and Saliva Concentrations of Biochemical Parameters in Men with prostate cancer and Benign prostate Hyperplasia.
Farahani H; Alaee M; Amri J; Baghinia MR; Rafiee M
Lab Med; 2020 May; 51(3):243-251. PubMed ID: 32374392
[TBL] [Abstract] [Full Text] [Related]
5. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With cancer.
Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
[TBL] [Abstract] [Full Text] [Related]
6. Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical prostatectomy.
Martini A; Marqueen KE; Falagario UG; Waingankar N; Wajswol E; Khan F; Fossati N; Briganti A; Montorsi F; Tewari AK; Stock R; Rastinehad AR
JAMA Netw Open; 2020 Mar; 3(3):e201913. PubMed ID: 32232450
[TBL] [Abstract] [Full Text] [Related]
7. Contemporary national trends in prostate cancer risk profile at diagnosis.
Fletcher SA; von Landenberg N; Cole AP; Gild P; Choueiri TK; Lipsitz SR; Trinh QD; Kibel AS
Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):81-87. PubMed ID: 31235801
[TBL] [Abstract] [Full Text] [Related]
8. Long-term Somatic Disease Risk in Adult Danish cancer Survivors.
Kjaer TK; Andersen EAW; Winther JF; Bidstrup PE; Borre M; Møller H; Larsen SB; Johansen C; Dalton SO
JAMA Oncol; 2019 Apr; 5(4):537-545. PubMed ID: 30844031
[TBL] [Abstract] [Full Text] [Related]
9. Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells.
Joshu CE; Peskoe SB; Heaphy CM; Kenfield SA; Mucci LA; Giovannucci EL; Stampfer MJ; Yoon G; Lee TK; Hicks JL; De Marzo AM; Meeker AK; Platz EA
Prostate; 2018 Feb; 78(3):233-238. PubMed ID: 29164645
[TBL] [Abstract] [Full Text] [Related]
10. Circulating Beta-2 Microglobulin and Risk of cancer: The Atherosclerosis Risk in Communities Study (ARIC).
Prizment AE; Linabery AM; Lutsey PL; Selvin E; Nelson HH; Folsom AR; Church TR; Drake CG; Platz EA; Joshu C
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):657-64. PubMed ID: 26908438
[TBL] [Abstract] [Full Text] [Related]
11. Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.
Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):28-34. PubMed ID: 26754263
[TBL] [Abstract] [Full Text] [Related]
12. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract] [Full Text] [Related]
13. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for prostate cancer Genetics (ICPCG).
Xu J; Lange EM; Lu L; Zheng SL; Wang Z; Thibodeau SN; Cannon-Albright LA; Teerlink CC; Camp NJ; Johnson AM; Zuhlke KA; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Maier C; Luedeke M; Vogel W; Schleutker J; Wahlfors T; Tammela T; Schaid D; McDonnell SK; DeRycke MS; Cancel-Tassin G; Cussenot O; Wiklund F; Grönberg H; Eeles R; Easton D; Kote-Jarai Z; Whittemore AS; Hsieh CL; Giles GG; Hopper JL; Severi G; Catalona WJ; Mandal D; Ledet E; Foulkes WD; Hamel N; Mahle L; Moller P; Powell I; Bailey-Wilson JE; Carpten JD; Seminara D; Cooney KA; Isaacs WB;
Hum Genet; 2013 Jan; 132(1):5-14. PubMed ID: 23064873
[TBL] [Abstract] [Full Text] [Related]
14. Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.
King AC; Livermore A; Laurila TA; Huang W; Jarrard DF
Urol Oncol; 2013 Aug; 31(6):739-43. PubMed ID: 21816639
[TBL] [Abstract] [Full Text] [Related]
15. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population.
Lavie O; Narod S; Lejbkowicz F; Dishon S; Goldberg Y; Gemer O; Rennert G
Ann Oncol; 2011 Apr; 22(4):964-966. PubMed ID: 20924075
[TBL] [Abstract] [Full Text] [Related]
16. Participation of older patients with prostate cancer in Medicare eligible trials.
Craig BM; Gilbert SM; Herndon JB; Vogel B; Quinn GP
J Urol; 2010 Sep; 184(3):901-6. PubMed ID: 20643449
[TBL] [Abstract] [Full Text] [Related]
17. The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.
Jaboin JJ; Hwang M; Lopater Z; Chen H; Ray GL; Perez C; Cai Q; Wills ML; Lu B
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1330-5. PubMed ID: 20605361
[TBL] [Abstract] [Full Text] [Related]
18. Poly(adenylic acid) complementary DNA real-time polymerase chain reaction in pancreatic ductal juice in patients undergoing pancreaticoduodenectomy.
Oliveira-Cunha M; Byers RJ; Siriwardena AK
Pancreas; 2010 Mar; 39(2):171-4. PubMed ID: 19940796
[TBL] [Abstract] [Full Text] [Related]
19. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics.
Kristiansen G; Fritzsche FR; Wassermann K; Jäger C; Tölls A; Lein M; Stephan C; Jung K; Pilarsky C; Dietel M; Moch H
Br J Cancer; 2008 Sep; 99(6):939-48. PubMed ID: 18781151
[TBL] [Abstract] [Full Text] [Related]
20. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon cancer Family Registry.
Poynter JN; Figueiredo JC; Conti DV; Kennedy K; Gallinger S; Siegmund KD; Casey G; Thibodeau SN; Jenkins MA; Hopper JL; Byrnes GB; Baron JA; Goode EL; Tiirikainen M; Lindor N; Grove J; Newcomb P; Jass J; Young J; Potter JD; Haile RW; Duggan DJ; Le Marchand L;
Cancer Res; 2007 Dec; 67(23):11128-32. PubMed ID: 18056436
[TBL] [Abstract] [Full Text] [Related]
[Next]
